| INTRODUC TI ON
The use of saliva for laboratory tests has been investigated in various medical areas because saliva could be used as a noninvasive diagnostic tool. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] An important prerequisite for the use of saliva in diagnostic workup is that the salivary levels of the marker associated with a given disorder should mirror the profile of the marker in biological samples used as gold standard in medical practice. Previous observations indicated that correlations between plasma concentrations and saliva concentrations are detectable for some but not for all analytes. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] It is well established that small molecules as phosphorus and urea are measurable in saliva. 20, 21 High plasma levels of phosphorus and urea were reported in astronauts during space missions and in terrestrial models of microgravity. [22] [23] [24] In these particular settings, high plasma levels of phosphorus and urea are considered secondary to alterations in bone and muscle metabolism leading to loss of bone mass and muscle mass. 22 As part of a project about the use of saliva tests in space medicine, 25 this study investigated methodological aspects in saliva measurements (duplicate samples, saliva from different sites of collection, day-to-day variability, time of collection, effects of freezing/thawing) and correlations between plasma concentrations and saliva concentrations. Methodological aspects were investigated in healthy volunteers, whereas plasmasaliva correlations were investigated in patients with kidney disease because low kidney function increases the levels of phosphorus and urea not only in plasma but also in saliva.
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| ME THODS
This observational study was conducted in accordance with the ethical principles of the Declaration of Helsinki and was ap- to explore the use of saliva for monitoring metabolic changes associated with reduction in bone mass and muscle mass. 25 Healthy volunteers were enrolled from the department staff for analyses on methodological aspects. Patients with chronic kidney disease (CKD) were targeted for analyses on correlations between plasma levels and salivary levels because kidney dysfunction generally increases plasma levels both of phosphorus and urea. 26 CKD patients were enrolled from the outpatient clinic of the University Hospital. Exclusion criteria for the healthy group were the presence or the report of a recent acute disease or of a chronic disease at the medical examination, or the report of pharmacological treatment. The selection criterion for the CKD group was a confirmed diagnosis of CKD according to standard definitions. 26 Given that CKD modifies plasma phosphorus and plasma urea proportionally to kidney dysfunction, the enrollment of CKD patients was stratified by CKD stage to have at least five patients in each CKD stage, that is, to have a continuum of kidney function ranging from normal levels to severe reduction. The study included also a small group of CKD patients on regular chronic hemodialysis to investigate the relationships of saliva phosphorus and saliva urea with dialysis-induced changes in plasma phosphorus and plasma urea.
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Smoking was an exclusion criterion for the group of healthy volunteers and for the CKD group to exclude the effect of this confounding on saliva composition. 28 All participants were enrolled after having signed an informed consent.
Unless otherwise indicated, blood and saliva samples were collected early in the morning after an overnight fast. Blood samples were taken by peripheral venipuncture and rapidly centrifuged for plasma separation. Blood withdrawal was part of the standard routine workup programmed in the outpatient clinic for CKD patients and, in dialysis patients, was repeated as programmed for good medical practice after the completion of the morning, 4-hour, standard dialysis session. 27 Saliva samples were collected 1-2 minutes after blood withdrawal using a synthetic swap (Salivette, Sarstedt, Germany). 29 The protocol was designed to comply with the restraints of space missions in which the use of a swap is the standard method for saliva collection in the absence of gravity. The collection of saliva was not timed nor preceded by salivary flow stimulation with paraffin or other agents given that the restraints of space missions include also strict limitations in the time availability of astronauts, in the administration of substances to the astronauts, and in the use of materials or disposables, etc. The swap was rapidly centrifuged for saliva separation and for mucin removal. Unless otherwise indicated, laboratory measurements were performed using fresh saliva samples collected early in the morning under fasting condition (standard samples). Laboratory procedures were performed using automated biochemistry and commercially available kits (Abbott, IL, USA).
Saliva measurements were performed by the molybdate UV method
for phosphorus and by the urease/NADH method for urea. on mid-morning sample was selected in accordance with the schedule programmed for experiments in astronauts during space mission. 29 In experiments on frozen/thawed samples, a standard saliva sample was split into two identical aliquots: One aliquot was kept at 2-4°C for one hour while the other aliquot was frozen and thawed at 2-4°C within the same time. Saliva and blood samples of the CKD group were for investigations about correlations between plasma phosphorus and saliva phosphorus and between plasma urea and saliva urea. Results were analyzed using Student's t-test for paired observations, simple correlation coefficient (R), and linear regression.
The report of results included mean ± SEM and 95% confidence intervals (95% CI).
| RE SULTS
The healthy group was made of 9 men and 6 women with age 35 ± 5 years, whereas the CKD group was made of 17 men and 13
women with age 37 ± 3 years. The saliva concentrations of phosphorus and urea were in all measurements well above the detection limits of laboratory tests (0.3 mmol/L). Table 1 summarizes the results in the healthy group with the use of standard samples (saliva collected early in the morning after an overnight fast and processed as fresh sample) with regard to blind duplicates, site of collection, and day-to-day variability. Table 1 shows that saliva concentrations of phosphorus and urea of blind duplicates were almost identical and highly correlated. The difference of duplicate samples from the mean was 1.85% for phosphorus and 5.60% for urea (technical error). With regard to the possible effects of the site of saliva collection, data indicated that saliva concentrations of phosphorus and urea of samples from the right and the left vestibulum oris were almost identical and highly correlated. With regard to day-to-day variability, findings were similar also in the comparisons of saliva concentrations of phosphorus and urea between samples of different days, although the value of the R was apparently lower for saliva phosphorus as compared to saliva urea. TA Standard samples: non-stimulated fresh saliva collected with the use of a synthetic swap early in the morning after an overnight fast. Mid-morning samples: non-stimulated fresh saliva collected with the use of a synthetic swap in the morning three hours after the completion of breakfast. Frozen/thawed samples: non-stimulated saliva collected with the use of a synthetic swap early in the morning after an overnight fast. * P < .001, ** P < .01.
In the CKD group, standard saliva samples and plasma samples collected 1-2 minutes before saliva were apparently different for phosphorus concentration that was 4.80-time higher in saliva (mean ± SEM in saliva and plasma = 7.78 ± 0.79 and 1.62 ± 0.14 mmol/L, P < .001 by t test for paired data). Vice versa, saliva and plasma were almost identical for urea concentration 
| D ISCUSS I ON
The present study investigated methodological aspects in labora- and saliva urea were accurate because the difference between duplicates ranged below 6%, whereas the correlation coefficients between duplicates ranged above 0.9. The site of the saliva collection did not add significant variability either for phosphorus, or for urea.
The correlation coefficient between standard measurements performed in different days was >0.9 for saliva urea and ≈0.6 for saliva phosphorus indicating that, at least in the group of 15 healthy volunteers under analysis, the day-to-day variability was minor for saliva urea and larger for saliva phosphorus. It can be speculated that the day-to-day variability could reflect the influence of dietary factors, although other possibilities could not be excluded. The lack of previous data on blind duplicates, site of saliva collection, and day-to-day variability precluded the comparison with other studies. To comply with the restraints of space missions, the study protocol did not include any procedure to stimulate or to time the collection of saliva samples. Thus, it is unknown if the accuracy of results could differ in the case of stimulated or timed saliva collections.
The concentrations of phosphorus and urea were lower when saliva was collected mid-morning after the breakfast as compared to standard samples collected early in the morning under fasting conditions. This datum was in agreement with the observation that saliva osmolality is lower in mid-morning samples as compared to early morning samples. 3 It is reasonable to propose that the lower concentrations in mid-morning saliva reflected a higher dilution of saliva because an increase in plasma phosphorus and plasma urea was actually expected after the breakfast. 
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